Publication Abstract Display
Type: Published Abstract
Title: Mitochondrial DNA haplogroups and CSF neuroinflammation in the CHARTER cohort.
Authors: Hulgan T, Samuels D, Ellis R, Bush W, Letendre S, Franklin D, Grant I, Kallianpur A
Year: 2015
Publication: 2015 Annual Conference on Retroviruses and Opportunistic Infections
Volume: Issue: Pages:
Abstract:Background: Neurocognitive impairment (NCI) remains an important complication in the combination antiretroviral therapy (CART) era, and is associated with neuroinflammation in cerebrospinal fluid (CSF). Mitochondrial DNA (mtDNA) haplogroups are ancestry-related patterns of single-nucleotide polymorphisms that are associated with differential mitochondrial function in model systems, neurodegenerative diseases in HIV-uninfected populations, and HIV- and CART-associated outcomes in HIV-infected persons. We hypothesized that mtDNA haplogroups would be associated with neuroinflammation in HIV-infected adults. Methods: CHARTER is a U.S.-based observational study of HIV-infected adults who underwent standardized neurocognitive assessments. Participants without confounding neurocognitive comorbidities and who consented to DNA collection underwent mtDNA sequencing from whole blood. A subset also underwent lumbar puncture. IL-6, IL-8, TNF-α (high-sensitivity), VEGF, IP-10, and novel soluble biomarkers of brain iron homeostasis, antioxidant defense, and inflammation- ceruloplasmin (CP) and haploglobin (HP)- were measured in CSF by immunoassay. Haplogroups were assigned using HaploGrep. Multivariable regression of mtDNA haplogroups and log-transformed CSF biomarkers were stratified by genetic ancestry using whole-genome nuclear DNA genotyping (European [EA], African [AA], or admixed Hispanic ancestry [HA]), and adjusted for age, sex, CART, detectable CSF HIV RNA, and CD4 nadir. Results: Haplogroups could be assigned in 385 subjects with evaluable CSF (45% EA, 44% AA, 11% HA, 20% female, median age 43 years, CD4 nadir 175 cells/mm3, 74% on CART). Statistically significant adjusted haplogroupbiomarker associations included higher IP-10 in HA subjects with haplogroup B (N=12; p=0.03) and higher CP with haplogroups L1 (N=32) and L2 (N=52) in AA subjects (p=0.02 and 0.01, respectively). Among EA subjects, mtDNA haplogroups were not significantly associated with these CSF biomarkers. Several additional associations of IL-6, IL- 8, IP-10, and TNF-α with age, sex, CD4 nadir, CSF HIV detectability, and CART were observed independent of mtDNA haplogroup. Conclusions: We observed associations between mtDNA haplogroups and CSF IP-10 and CP in HA and AA CHARTER subjects, respectively, independent of other potential confounders. These preliminary results suggest novel mechanisms of neuroinflammation and perhaps NCI that merit further exploration.

return to publications listing